Solid dispersion adsorbate technique for improved dissolution and flow properties of lurasidone hydrochloride: characterization using 3² factorial design

References

• McIntyre RS, Cha DS, Kim RD, et al. A review of FDA-approved treatment options in bipolar depression. CNS Spectr. 2013;18:4–20.
   PubMed Web of Science ®Google Scholar
• Shah S, Parmar B, Soniwala M, et al. Design, optimization, and evaluation of lurasidone hydrochloride nanocrystals. AAPS PharmSciTech. 2016;17:1150–1158.
   PubMed Web of Science ®Google Scholar
• Shan L, Pan Y, Jian HH, et al. Enhanced dissolution and oral bioavailability of lurasidone hydrochloride nanosuspensions prepared by antisolvent precipitation ultrasonication method. RSC Adv. 2016;54:1–9.
   Google Scholar
• Panpan Y, Shan L, Shuang SZ, et al. Enhanced oral bioavailability and diminished food effect of lurasidone hydrochloride nanosuspensions prepared by facile nanoprecipitation based on dilution. Powder Technol. 2017;312:11–20.
   Web of Science ®Google Scholar
• Qian S, Heng W, Wei Y, et al. Coamorphous lurasidone hydrochloride-saccharin with charge assisted hydrogen bonding interaction shows improved physical stability and enhanced dissolution with pH-independent solubility behavior. Crys Growth Des. 2015;5:1–38.
   Google Scholar
• Miao Y, Sun J, Chen G, et al. Enhanced oral bioavailability of lurasidone by selfnanoemulsifying drug delivery system in fasted state. Drug Dev Ind Pharm. 2016;13:1234–1240.
   Google Scholar
• Madan J, Pawar K, Dua K. Solubility enhancement studies on lurasidone hydrochloride using mixed hydrotropy. Int J Pharma Investig. 2015;5:114–120.
   PubMed Web of Science ®Google Scholar
• Mittal A, Yadav M, Choudhary D, et al. Enhancement of solubility of lurasidone HCL using solid dispersion technique. Int J Res Ayurveda Pharm. 2014;5:632–637.
   Google Scholar
• Maulvi FA, Dalwadi SJ, Thakkar VT, et al. Improvement of dissolution rate of aceclofenac by solid dispersion technique. Powder Technol. 2011;207:47–54.
   Web of Science ®Google Scholar
• Pandya R, Mehta T, Gohel M. Amalgamation of solid dispersion and adsorption technique. J Therm Anal Calorim. 2015;120:699–709.
   Web of Science ®Google Scholar
• Jammula S, Patra C, Swain S, et al. Improvement in the dissolution rate and tableting properties of cefuroxime axetil by melt-granulated dispersion and surface adsorption. Acta Pharmaceutica Sinica B. 2013;3:113–122.
   Google Scholar
• Gupta M, Goldman D, Bogner R, et al. Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent. Pharma Dev Technol. 2001;6:563–572.
   PubMed Web of Science ®Google Scholar
• Sruti J, Patra CH, Swain S, et al. Improvement in dissolution rate of cefuroxime axetil by using Poloxamer 188 and Neusilin US2. Ind J Pharm Sci. 2013;75:67–75.
   PubMed Web of Science ®Google Scholar
• Kaushik D, Singh N, Arora A. Enhancement of dissolution profile of gliclazide by solid dispersion adsorbates. Lat Am J Pharm. 2011;30:2057–2060.
   Web of Science ®Google Scholar
• Ying W, Qinfu Z, Yanchen H, et al. Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica. Int J Nanomed. 2013;8:4015–4031.
   PubMed Web of Science ®Google Scholar
• Yuasa H, Asahi D, Takashima Y, et al. Application of calcium silicate for medicinal preparation: I – solid preparation adsorbing an oily medicine to calcium silicate. Chem Pharm Bull. 1994;42:2327–2331.
   PubMed Web of Science ®Google Scholar
• Yuasa H, Takashima Y, Kanaya Y. Studies on the development of intragastric floating and sustained release preparation: I – application of calcium silicate as a floating carrier. Chem Pharm Bull. 1996;44:1361–1366.
   Web of Science ®Google Scholar
• Christina MH, Albrecht S, Claudia S. Leopold suitability of various excipients as carrier and coating materials for liquisolid compacts. Drug Dev Ind Pharm. 2011;37:1200–1207.
   PubMed Web of Science ®Google Scholar
• Chang HC, Park SH, Kang BK. Taste-masked pharmaceutical composition for oral administration and a process for the preparation thereof. WO2013058496A1; 2013.
   Google Scholar
• Yumi F, Nobuaki H, Tomoka TN, et al. Photostable solid dispersion of nifedipine by porous calcium silicate. Chem Pharm Bull. 2016;64:1218–1221.
   PubMed Web of Science ®Google Scholar
• Xifeng Z, Chunguang L, George BL, et al. Preparation and characterisation of solid dispersions of tanshinone IIA, cryptotanshinone and total tanshinones. Asian J Pharm Sci. 2017;12:85–97.
   PubMedGoogle Scholar
• Higuchi T, Connors K. Phase-solubility techniques. Adv Anal Chem Instrum. 1965;4:117–123.
   Google Scholar
• Sandrien J, GuyVan M. Review: physical chemistry of solid dispersions. J Pharm Pharmacol. 2009;61:1571–1586.
   PubMed Web of Science ®Google Scholar
• Dureja DH, Madan AK. Solid dispersion adsorbates for enhancement of dissolution rates of drugs. PDA J Pharm Sci Tech. 2007;61:97–101.
   PubMedGoogle Scholar
• Jadupati M, Amit KN. Formulation and statistical optimization of multiple unit ibuprofen loaded buoyant system using 23 factorial design. Chem Eng Res Design. 2012;90:1834–1846.
   Web of Science ®Google Scholar
• Bolton S, Bon C. Optmization techniques in pharmaceutical statistics: practical and clinical applications. New York (NY): Marcel Dekker, Inc.; 1997; p. 215–s249.
   Google Scholar
• Singh B, Kumar R, Ahuja N. Optimizing drug delivery systems using systematic design of experiments – part I: fundamental aspects. Crit Rev Ther Drug Carrier Syst. 2005;22:27–105.
   PubMed Web of Science ®Google Scholar
• United States Food and Drug Administration. Guidelines for dissolution testing of Latuda. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/200603s000ltr.pdf.
   Google Scholar
• Duan JZ, Riviere K, Marroum P. In vivo bioequivalence and in vitro similarity factor (f2) for dissolution profile comparisons of extended release formulations: how and when do they match. Pharm Res. 2011;28:1144–1156.
   PubMed Web of Science ®Google Scholar
• Silvina GC, Sergio SB, Carlos EL, et al. Improved albendazole dissolution rate in pluronic 188 solid dispersions. AAPS PharmSciTech. 2010;11:1518–1525.
   PubMed Web of Science ®Google Scholar
• United States Pharmacopeia-40, NF-35, United States Pharmacopeial Convention, Inc.; 2017.
   Google Scholar
• Nemanja K, Kyriakos K, Irena H, et al. Solubility enhancement of desloratadine by solid dispersion in poloxamers. Int J Pharm. 2012;436:161–170.
   PubMedGoogle Scholar
• Yan X, Guowen L, Xiurong Y, et al. Preparation and in vitro evaluation of solid dispersions of total flavones of Hippophae rhamnoides L. AAPS PharmSciTech. 2009;10:631–640.
   PubMed Web of Science ®Google Scholar
• Newa M, Bhandari KH, Li DX, et al. Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. Int J Pharm. 2007;343:228–237.
   PubMed Web of Science ®Google Scholar
• Raymond CR, Paul JS, Marian EQ. Handbook of pharmaceutical excipients. Great Britain: RPS Publishing, 2009:129–133.
   Google Scholar
• Ito Y, Kusawake T, Ishida M, et al. Oral solid gentamicin preparation using emulsifier and adsorbent. J Control Release. 2005;105:23–31.
   PubMed Web of Science ®Google Scholar
• Patel DM, Patel NM, Patel VF, et al. Floating granules of ranitidine hydrochloride-gelucire 43/01: formulation optimization using factorial design. AAPS PharmSciTech. 2007;8:E1–E7.
   PubMed Web of Science ®Google Scholar
• Passerini N, Albertini B, Gonzalez ML, et al. Preparation and characterisation of ibuprofen-poloxamer 188 granules obtained by melt granulation. Eur J Pharm Sci. 2002;15:71–78.
   PubMed Web of Science ®Google Scholar
• Sharma S, Sher P, Badve S, et al. Adsorption of meloxicam on porous calcium silicate: characterization and tablet formulation. AAPS PharmSciTech. 2005;6:E618–E625.
   PubMed Web of Science ®Google Scholar
• Yotsanan W, Sontaya L, Chaweewan J, et al. Enhanced dissolution and oral bioavailability of nifedipine by spontaneous emulsifying powders: Effect of solid carriers and dietary state. Eur J Pharm Biopharm. 2015;91:25–34.
   PubMed Web of Science ®Google Scholar
• Ivanisevic I. Physical stability studies of miscible amorphous solid dispersions. J Pharm Sci. 2010;99:4005–4012.
   PubMed Web of Science ®Google Scholar
• Marsac PJ, Rumondor ACF, Nivens DE, et al. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(-vinylpyrrolidone). J Pharm Sci. 2009;99:169–185.
   Web of Science ®Google Scholar